Actavis UK Ltd

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk
Medical Information Fax:

Summary of Product Characteristics last updated on the eMC: 10/06/2011
SPC Diazemuls

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   25-Mar-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Sections 4.3, 4.4, 4.5, 4.7, 4.8, 4.9 and 10 updated as a result of the update of the Company Core Safety Information.
Updated on 19/09/2008 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Date of revision of text on the SPC:   31-Jul-2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to MA Holder
Updated on 27/11/2007 and displayed until 19/09/2008
Reasons for adding or updating:
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   07/2005
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7: Change to Marketing Authorisation Holder
Section 8: Change to Marketing Authorisation Number
Updated on 07/01/2005 and displayed until 27/11/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 06/01/2005 and displayed until 07/01/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 02/08/2001 and displayed until 06/01/2005
Reasons for adding or updating:
  • Transferred from eMC version 1
  • Pending awaiting re-submission
Updated on 06/09/1999 and displayed until 02/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   diazepam